Smart Pills Market Revenue is Expected to ReachUS$ 3.1 Bn By 2026

Smart Pills Market rising to a value of US$ 3.1 Bn By 2026
Integration of smart technologies in pills has instrumented a ground-breaking transformation in the
global healthcare marketplace. Initially, consumers and patients were diffident towards invasive
surgical procedures and drug administration, albeit, their perspectives have undergone changes.
There is a growing uptake for indigestible medical devices, which has propelled the consumption of
smart pills. Elements such as cameras, trackers and sensors are being integrated in smart pills,
making them a key tool to assess the health of consumer from within the body.
In the near future, smart pills will gain grounds in diagnostics and health monitoring applications.
These unique devices are being widely used in non-invasive examination of gastrointestinal
diseases. Companies developing smart pills are extending their functions in assessment of health
across a range of physiological metrics. With evolution in medical technology, the data procured by
smart pills is becoming highly accurate and these pills are strengthening the patient adherence
towards measuring medications.
Smart Pills Market Research Report Overview @
Persistence Market Research’s recently published report on the global smart pills market projects
that the demand for these miniaturized devices will gain traction during the forecast period, 20172026. The report projects that by the end of 2026, more than US$ 3.1 Bn worth of smart pills will
be sold globally. Over the forecast period, the global smart pills market is pegged to expand
robustly at a CAGR of 14.5%. The study projects that the future prospects of smart pills will
majorly revolve around their growing use as a device that can monitor daily medicine intake of
The report estimates that in 2017, smart pills worth over US$ 300 Mn have been sold globally for
their use in drug delivery applications. Increasing non-adherence of patients towards medication
intake has driven the medical professionals such as doctors in compelling their patients to consume
smart pills. Miniscule sensors embedded in smart pills are being used to detect the presence of
elements in stomach, and this information is being transmitted to the patch worn by patients. The
procured data reveals the daily medicine intake of the patients and allows the doctors to facilitate
effective drug delivery while monitoring the health of patients. The report also reveals that capsule
endoscopy will be the leading application in the global smart pills market through 2026.
Through 2026, majority of medical professionals will allow the patients to consume smart pills and
get them positioned in the esophagus. Effectiveness of smart pills in detecting the presence of
different elements being consumed through food or medicine will continue to drive their positioning
in the esophagus target area. By the end of 2026, more than US$ 1.2 Bn worth of smart pills to be
sold in the global market will be used for targeting the esophagus.
Request Sample [email protected]
The report has further revealed that the demand for smart pills is expected to be high North America
and Europe. Robust healthcare infrastructure in the US is expected to drive the expansion of North
America’s smart pills market through 2026. The report also reveals that leading players in the global
smart pills market are based in North America and several European countries. Companies namely,
CapsoVision, Inc., Given Imaging, Inc., Medimetrics S.A. de C.V., Olympus Corporation, Bio-
Images Research Limited, Medtronic, Proteus digital Health, MediSafe, Boston Scientific
Corporation, and GE Healthcare are expected to spearhead the global production of smart pills
through 2026.